Literature DB >> 33422826

Does cognitive impairment in bipolar disorder impact on a SIMPLe app use?

Caterina Del Mar Bonnín1, Brisa Solé1, María Reinares1, Aitana García-Estela2, Ludovic Samalin3, Anabel Martínez-Arán1, José Sánchez-Moreno1, Francesc Colom4, Eduard Vieta5, Diego Hidalgo-Mazzei6.   

Abstract

BACKGROUND: Smartphone apps are becoming increasingly used by service users in mental health care and research for diverse aims. However, it is well-known the high prevalence of cognitive impairment in some people suffering from severe mental illnesses such as bipolar disorder (BD), which impacts on their psychosocial functioning and quality of life. In this context, the main aim of this paper is to investigate through exploratory analyses the role of specific cognitive deficits in the retention, engagement, and usability of a psychoeducational smartphone app in a group of patients with BD.
METHODS: 51 remitted BD patients were asked to use the app for 3 months. Baseline and 3-months follow-up clinical and usability assessments were conducted. Twenty-seven independent results from a comprehensive neurocognitive test of the same participants were retrieved separately of the 2 years before or after the use of the app. Post-hoc exploratory analyses were carried out using Spearman correlations to identify significant cognitive deficits domains influencing the usability and retention with the app.
RESULTS: There were no statistically significant cognitive variables associated with the use, reported usability or retention with the app. Some variables associated with executive functions, verbal and visual memory correlated significantly with previous use of smartphones. LIMITATIONS: Post-hoc analysis with a limited sample size.
CONCLUSION: These preliminary results suggests that patients with BD and mild cognitive deficits do not present any limitation in using mental health apps. In our case, the adoption of a user-centred design in the development process of the app could have mitigated the participants' difficulties when using the app.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; app; cognition; smartphone; usability

Mesh:

Year:  2020        PMID: 33422826     DOI: 10.1016/j.jad.2020.12.168

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  An examination of neurocognition and theory of mind as predictors of engagement with a tailored digital therapeutic in persons with serious mental illness.

Authors:  Tate F Halverson; Julia Browne; Samantha M Thomas; Paige Palenski; Roger Vilardaga
Journal:  Schizophr Res Cogn       Date:  2022-01-17

2.  Evaluating the quality, safety, and functionality of commonly used smartphone apps for bipolar disorder mood and sleep self-management.

Authors:  Emma Morton; Jennifer Nicholas; Linda Yang; Laura Lapadat; Steven J Barnes; Martin D Provencher; Colin Depp; Michelle Chan; Rhea Kulur; Erin E Michalak
Journal:  Int J Bipolar Disord       Date:  2022-04-04

3.  Remote group therapies for cognitive health in schizophrenia-spectrum disorders: Feasible, acceptable, engaging.

Authors:  Daniel Mendelson; Élisabeth Thibaudeau; Geneviève Sauvé; Katie M Lavigne; Christopher R Bowie; Mahesh Menon; Todd S Woodward; Martin Lepage; Delphine Raucher-Chéné
Journal:  Schizophr Res Cogn       Date:  2021-12-06

4.  Efficacy of Smartphone Apps in Patients With Depressive Disorders: A Systematic Review.

Authors:  Alba Hernández-Gómez; María José Valdés-Florido; Guillermo Lahera; Nelson Andrade-González
Journal:  Front Psychiatry       Date:  2022-08-12       Impact factor: 5.435

5.  Behavioral and Self-reported Data Collected From Smartphones for the Assessment of Depressive and Manic Symptoms in Patients With Bipolar Disorder: Prospective Observational Study.

Authors:  Monika Dominiak; Katarzyna Kaczmarek-Majer; Anna Z Antosik-Wójcińska; Karol R Opara; Anna Olwert; Weronika Radziszewska; Olgierd Hryniewicz; Łukasz Święcicki; Marcin Wojnar; Paweł Mierzejewski
Journal:  J Med Internet Res       Date:  2022-01-19       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.